Detalles de la búsqueda
1.
Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence.
BMC Infect Dis;
15: 566, 2015 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-26652918
2.
Vaccination of boys or catch-up of girls above 11 years of age with the HPV-16/18 AS04-adjuvanted vaccine: where is the greatest benefit for cervical cancer prevention in Italy?
BMC Infect Dis;
15: 377, 2015 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26381489
3.
Modeling optimal cervical cancer prevention strategies in Nigeria.
BMC Cancer;
14: 365, 2014 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-24885048
4.
Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.
BMC Public Health;
14: 1222, 2014 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-25424716
5.
Identification of an Optimal COVID-19 Booster Allocation Strategy to Minimize Hospital Bed-Days with a Fixed Healthcare Budget.
Vaccines (Basel);
11(2)2023 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36851254
6.
Cost-effectiveness analysis of the bivalent compared with the quadrivalent human papillomavirus vaccines in Taiwan.
Value Health;
15(5): 622-31, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22867770
7.
Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada.
BMC Public Health;
12: 872, 2012 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-23061913
8.
Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models.
BMC Med;
9: 54, 2011 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-21569406
9.
Cost-effectiveness analysis of prophylactic cervical cancer vaccination in Japanese women.
Int J Gynecol Cancer;
20(3): 385-92, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20375802
10.
Risk factors for cervical cancer in women in China: A meta-model.
Womens Health (Lond);
16: 1745506520940875, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32787563
11.
Health economic assessment of a rabies pre-exposure prophylaxis program compared with post-exposure prophylaxis alone in high-risk age groups in the Philippines.
Int J Infect Dis;
97: 38-46, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32450291
12.
A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females.
BMC Public Health;
9: 401, 2009 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-19878578
13.
The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review.
Expert Rev Vaccines;
18(5): 439-455, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30887849
14.
An Asian regional analysis of cost-effectiveness of early irbesartan treatment versus conventional antihypertensive, late amlodipine, and late irbesartan treatments in patients with type 2 diabetes, hypertension, and nephropathy.
Value Health;
11(3): 354-64, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-17888064
15.
Is adding maternal vaccination to prevent whooping cough cost-effective in Australia?
Hum Vaccin Immunother;
14(9): 2263-2273, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29771574
16.
Critical appraisal of scientific posters comparing anemia treatments for cancer patients: applying ISPOR Task Force guidelines on methodological quality of retrospective studies.
Crit Rev Oncol Hematol;
63(2): 91-9, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17462908
17.
Cost effectiveness of levocetirizine in chronic idiopathic urticaria : a pooled analysis of two randomised controlled trials.
Clin Drug Investig;
26(1): 1-11, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17163229
18.
Evaluation of serogroup C and ACWY meningococcal vaccine programs: projected impact on disease burden according to a stochastic two-strain dynamic model.
Vaccine;
33(1): 268-75, 2015 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24103896
19.
Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths.
Vaccine;
32(6): 733-9, 2014 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-24291200
20.
Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium.
Vaccine;
31(37): 3962-71, 2013 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23777952